216 related articles for article (PubMed ID: 19389811)
1. Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNA.
Baniwal SK; Khalid O; Sir D; Buchanan G; Coetzee GA; Frenkel B
Mol Endocrinol; 2009 Aug; 23(8):1203-14. PubMed ID: 19389811
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasiveness.
Little GH; Baniwal SK; Adisetiyo H; Groshen S; Chimge NO; Kim SY; Khalid O; Hawes D; Jones JO; Pinski J; Schones DE; Frenkel B
Cancer Res; 2014 May; 74(10):2857-68. PubMed ID: 24648349
[TBL] [Abstract][Full Text] [Related]
3. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
[TBL] [Abstract][Full Text] [Related]
4. General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2.
Yu S; Jiang Y; Galson DL; Luo M; Lai Y; Lu Y; Ouyang HJ; Zhang J; Xiao G
J Biol Chem; 2008 Feb; 283(9):5542-53. PubMed ID: 18171674
[TBL] [Abstract][Full Text] [Related]
5. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC
Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908
[TBL] [Abstract][Full Text] [Related]
6. Runx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferation.
Baniwal SK; Little GH; Chimge NO; Frenkel B
J Cell Physiol; 2012 May; 227(5):2276-82. PubMed ID: 21809344
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer.
Khalid O; Baniwal SK; Purcell DJ; Leclerc N; Gabet Y; Stallcup MR; Coetzee GA; Frenkel B
Endocrinology; 2008 Dec; 149(12):5984-95. PubMed ID: 18755791
[TBL] [Abstract][Full Text] [Related]
8. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
Yuan H; Gong A; Young CY
Carcinogenesis; 2005 Apr; 26(4):793-801. PubMed ID: 15661808
[TBL] [Abstract][Full Text] [Related]
9. Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.
Li N; Chen M; Truong S; Yan C; Buttyan R
Prostate; 2014 Oct; 74(14):1400-10. PubMed ID: 25132524
[TBL] [Abstract][Full Text] [Related]
10. Negative modulation of androgen receptor transcriptional activity by Daxx.
Lin DY; Fang HI; Ma AH; Huang YS; Pu YS; Jenster G; Kung HJ; Shih HM
Mol Cell Biol; 2004 Dec; 24(24):10529-41. PubMed ID: 15572661
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation.
Hinoi E; Fujimori S; Wang L; Hojo H; Uno K; Yoneda Y
J Biol Chem; 2006 Jun; 281(26):18015-24. PubMed ID: 16613847
[TBL] [Abstract][Full Text] [Related]
12. Mutual transactivational repression of Runx2 and the androgen receptor by an impairment of their normal compartmentalization.
Kawate H; Wu Y; Ohnaka K; Takayanagi R
J Steroid Biochem Mol Biol; 2007; 105(1-5):46-56. PubMed ID: 17627815
[TBL] [Abstract][Full Text] [Related]
13. The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells.
van der Deen M; Akech J; Wang T; FitzGerald TJ; Altieri DC; Languino LR; Lian JB; van Wijnen AJ; Stein JL; Stein GS
J Cell Biochem; 2010 Mar; 109(4):828-37. PubMed ID: 20082326
[TBL] [Abstract][Full Text] [Related]
14. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
15. Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes.
Dai Y; Ngo D; Jacob J; Forman LW; Faller DV
Carcinogenesis; 2008 Sep; 29(9):1725-33. PubMed ID: 18487222
[TBL] [Abstract][Full Text] [Related]
16. High-Throughput Screen for Inhibitors of Androgen Receptor-RUNX2 Transcriptional Regulation in Prostate Cancer.
Vuong W; Tew BY; Little GH; Frenkel B; Jones JO
J Pharmacol Exp Ther; 2016 Nov; 359(2):256-261. PubMed ID: 27554677
[TBL] [Abstract][Full Text] [Related]
17. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.
Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K
Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227
[TBL] [Abstract][Full Text] [Related]
18. MINT, the Msx2 interacting nuclear matrix target, enhances Runx2-dependent activation of the osteocalcin fibroblast growth factor response element.
Sierra OL; Cheng SL; Loewy AP; Charlton-Kachigian N; Towler DA
J Biol Chem; 2004 Jul; 279(31):32913-23. PubMed ID: 15131132
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta.
Ziros PG; Georgakopoulos T; Habeos I; Basdra EK; Papavassiliou AG
J Bone Miner Res; 2004 Nov; 19(11):1892-904. PubMed ID: 15476590
[TBL] [Abstract][Full Text] [Related]
20. Ku is a novel transcriptional recycling coactivator of the androgen receptor in prostate cancer cells.
Mayeur GL; Kung WJ; Martinez A; Izumiya C; Chen DJ; Kung HJ
J Biol Chem; 2005 Mar; 280(11):10827-33. PubMed ID: 15640154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
